Dihydropyridine calcium antagonists: conscious choice | Zendy

О. Д. Остроумова | Zendy; В. В. Викентьев | Zendy; A. G. Abrosimov | Zendy; Е. А. Смолярчук | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dihydropyridine calcium antagonists: conscious choice

Author(s) -

О. Д. Остроумова,

В. В. Викентьев,

A. G. Abrosimov,

Е. А. Смолярчук

Publication year - 2017

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg29184

Subject(s) - amlodipine , dihydropyridine , calcium , medicine , pharmacodynamics , heart failure , pharmacology , pharmacokinetics , cardiology , blood pressure

This article contains information concerning the aspects of pharmacokinetics and pharmacodynamics of dihydropyridine calcium antagonists. The authors have discussed the evidence-based amlodipine treatment of arterial hypertension, ischemic heart disease and chronic heart failure. The authors present the comparison of the efficacy, safety and application characteristics of the different dihydropyridine calcium antagonists that can be used in specific clinical cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research